{"database": "openregs", "table": "documents", "rows": [["FDA-2016-D-4308-0010", "FDA", "FDA-2016-D-4308", "Reference 7 FDA Guidance for Industry Biological Product Deviation Reporting for Blood and Plasma Establishments October 2006 re Labeling of Red Blood Cell Units with Historical Antigen Typing Results Draft Guidance for Industry", "Supporting & Related Material", "Background Material", "2017-01-03T05:00:00Z", 2017, 1, null, null, "2017-01-03T15:14:03Z", null, 0, 0, "0900006482446f1d"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2016-D-4308-0010"], "units": {}, "query_ms": 0.32849598210304976, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}